• Spiroplasma eriocheiris Entry in Drosophila S2 Cells: Cytosk

  2026-06-10

  This study demonstrates that Spiroplasma eriocheiris enters Drosophila S2 cells primarily via clathrin-mediated endocytosis and macropinocytosis, with infection strictly dependent on both actin and microtubule dynamics. The findings highlight new mechanistic insights into host-pathogen interactions in invertebrate models and inform design of assays targeting cytoskeletal pathways.

• Isradipine (Dynacirc): Advancing Calcium Channel Selectivity

  2026-06-10

  Explore how Isradipine (Dynacirc) sets a new benchmark for selective L-type calcium channel inhibition in neurovascular research. This in-depth analysis reveals the unique scientific considerations, assay decisions, and translational impact of Isradipine, distinguishing its role from traditional pharmacological tools.

• Nilotinib (AMN-107): Dissecting BCR-ABL Signaling and Riboto

  2026-06-09

  Explore how Nilotinib (AMN-107) advances chronic myeloid leukemia research by enabling precise BCR-ABL pathway analysis and illuminating the intersection with ribotoxic stress signaling. This article delivers new insights for experimental design beyond standard workflows.

• MRE11:p.K464R Mutation Drives Olaparib Resistance in HGSOC

  2026-06-09

  Zhuang et al. identify the MRE11:p.K464R mutation as a novel molecular driver of resistance to the PARP inhibitor olaparib in high-grade serous ovarian cancer (HGSOC). Their study demonstrates how this mutation enhances DNA damage repair via increased interaction with RAD50 and RPS3, providing new insight into resistance mechanisms and potential biomarkers for therapy monitoring.

• Autopalmitoylation of IDH1-R132H Links Lipid Metabolism to O

  2026-06-08

  This study uncovers a novel regulatory mechanism in which autopalmitoylation at C269 of mutant IDH1-R132H enhances its neomorphic activity, driving oncometabolite production and metabolic reprogramming in cancer cells. The findings highlight the intersection of lipid metabolism and epigenetic dysregulation in IDH1-mutant cancers, suggesting new therapeutic vulnerabilities.

• Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Workf

  2026-06-08

  The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) provides broad-spectrum protection against serine, cysteine, acid proteases, and aminopeptidases during protein extraction and analysis, without interfering with downstream applications sensitive to divalent cations. It is not suitable for workflows that require inhibition of metalloproteases via EDTA.

• Parathyroid hormone (1-34) (human): New Insights into Valvul

  2026-06-07

  Explore how Parathyroid hormone (1-34) (human) advances bone metabolism and valvular calcification research through newly elucidated PTH-induced endothelial mechanisms. This article uncovers unique assay considerations and translational opportunities, providing foundational knowledge for innovative calcium regulation studies.

• Ouabain as a Selective Na+/K+-ATPase Inhibitor: Applied Work

  2026-06-06

  Ouabain stands out as a gold-standard selective Na+/K+-ATPase inhibitor, enabling precision in cardiovascular, cellular signaling, and senolytic research. This article details robust protocols, advanced use-cases, and practical troubleshooting strategies that maximize experimental reliability and translational impact using APExBIO’s Ouabain.

• BGJ398 (NVP-BGJ398) in FGFR Signaling and Oncology Research

  2026-06-05

  BGJ398 (NVP-BGJ398) sets a new standard for dissecting FGFR signaling in cancer and developmental biology, offering unmatched selectivity and potency for both cell-based and in vivo assays. This guide delivers actionable workflows, species-specific insights, and troubleshooting strategies to maximize reproducibility and translational impact in FGFR-driven malignancies research.

• ECL Chemiluminescent Substrate Detection Kit: Precision for

  2026-06-05

  Unlock ultrasensitive HRP chemiluminescence with the ECL Chemiluminescent Substrate Detection Kit (Hypersensitive). This kit empowers researchers to confidently detect low-abundance proteins on nitrocellulose and PVDF membranes, offering extended signal duration and unmatched background suppression for advanced immunoblotting workflows.

• Tetrazolium (chloride): Precision Tool for Mitochondrial Ass

  2026-06-04

  Tetrazolium (chloride), also known as Tetrazolium Red or TTC, is a validated redox indicator used for mitochondrial function and cell viability assays. It offers direct, quantitative readouts of mitochondrial dehydrogenase activity and is integral for tissue viability discrimination, particularly in ischemic injury models.

• Ribonuclease R (20 U/μL): Transforming Circular RNA Enrichme

  2026-06-04

  Harness the power of Ribonuclease R (20 U/μL) for precise circular RNA enrichment and robust RNA structure analysis. Discover workflow enhancements, troubleshooting strategies, and real-world applications inspired by recent studies on inflammation and DNA damage.

• Autophagy Modulates Resveratrol-Induced Apoptosis in RCC Cel

  2026-06-03

  This study reveals that autophagy acts as a survival mechanism, suppressing resveratrol-induced apoptosis in renal cell carcinoma 786-O cells. The findings highlight the interplay between reactive oxygen species, caspase-3 activation, and autophagy, suggesting that co-targeting autophagy may enhance resveratrol efficacy in RCC therapy.

• HMGB1-Loaded Exosomes Mediate Glomerular Injury in Lupus Nep

  2026-06-03

  This study demonstrates that HMGB1 encapsulated in podocyte-derived exosomes plays a central role in glomerular endothelial cell (GEC) injury in lupus nephritis by upregulating TRIM27. The findings reveal a mechanistic link between exosome-mediated signaling and endothelial dysfunction, offering new insights for understanding and targeting exosome pathways in autoimmune kidney disease.

• TAK-242: Pioneering TLR4 Inhibition for Translational Resear

  2026-06-02

  Explore how TAK-242 (Resatorvid) redefines TLR4 pathway modulation, enabling translational researchers to dissect and therapeutically target inflammatory and neurovascular diseases. This article blends mechanistic insights, validated protocols, and strategic foresight, offering a roadmap for deploying TAK-242 in next-generation immunology and neuroinflammation research.

15404 records 1/1027 page Next 12345 下5页 Last page